ImmuPharma Share Price (IMM)

21.80 +0.30 (+1.40%) delayed: 1:25AM BST
Bid price 21.70 Open price 21.54
Ask price 21.90 Prev close 21.80
High price 22.60 Spread 0.91%
Low price 21.50 Volume 338,583

Register now for FREE live ImmuPharma share prices, ImmuPharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get ImmuPharma Level 2 Data, indepth research tools and investor commentary for ImmuPharma (IMM) and other London Stock Exchange equities.

ImmuPharma Share Price Chart

Advanced Charts >>

Register now for FREE ImmuPharma share price charts

ImmuPharma Share Price Information

Name ImmuPharma Epic IMM
Sector Pharmaceuticals & Biotechnology ISIN GB0033711010
Activites ImmuPharma PLC (formerly General Industries PLC) is developing innovative therapies for specialist diseases, It is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by: High unmet medical need; Low marketing costs; Relatively low development costs.. Founded first in Basel, Switzerland in 1999 and led by an experienced management team, ImmuPharma now has important R&D collaboration arrangements with highly respected health and medical research laboratories in Europe. The company plans either to bring its drug candidates to market itself, or to license them in corporate deals to other pharmaceutical companies. Index n/a

ImmuPharma Key Numbers

Latest Share Price (p) 21.80 Net Gearing (%) -25.66
Market Capitalisation (£m) 29.99 Gross Gearing (%) 28.75
Shares in issue (m) 139.47 Debt Ratio 8.05
P/E Ratio -4.53 Debt-to-Equity Ratio 0.22
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.40
Dividend Yield (%) 0.00 Price to book value 8.40
Dividend cover (x) 0.00 ROCE (%) -179.95
Earning per share (p) -4.75 EPS Growth (%) -4.63
52 week high / low 193.00 / 19.00 DPS Growth (%) n/a

ImmuPharma Director Deals

Dec.Date Type Director Pos No. of Shares
28/01/2013 SELL Dr Ajay Agrawal RES 62,129
24/01/2012 BUY Dr Franco Di Muzio NED 60,950
24/01/2012 BUY Dr Ajay Agrawal RES 62,169
23/07/2009 SELL Richard Warr RES 6,250,000
23/07/2009 SELL Dimitri Dimitriou CEO 6,250,000

More ImmuPharma Director Deals >>

ImmuPharma Company News

16:40 10/07/2018

Second Price Monitoring Extn

RNS Number : 2176U Immupharma PLC 10 July 2018   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price...

16:35 10/07/2018

Price Monitoring Extension

RNS Number : 2171U Immupharma PLC 10 July 2018   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices...

12:16 28/06/2018

Result of AGM

RNS Number : 8788S Immupharma PLC 28 June 2018                                                                                                                                28 JUNE 2018   This announcement contains inside information for the purposes of...

More ImmuPharma Company News >>

Register now for FREE ImmuPharma company news

ImmuPharma Share Price Discussions

2 months ago

IMMUPHARMA - small bio, big potential (IMM)

From today's Times: Tiddler to watch "ImmuPharma, steady at 46p, the biotech group which has a treatment of the disease Lupus in phase II trials, could benefit from the failure this week of trials of rival drug Rituxan. ImmuPharma's housebroker, Panmure Gordon, believes its client may attract...

Register now for FREE ImmuPharma share price discussions